PMID- 16550306 OWN - NLM STAT- MEDLINE DCOM- 20070515 LR - 20181113 IS - 0910-8327 (Print) IS - 0910-8327 (Linking) VI - 21 IP - 2 DP - 2006 Mar TI - Perioperative and clinical-angiographic late outcome of total arterial myocardial revascularization according to different composite original graft techniques. PG - 69-77 AB - Total arterial myocardial revascularization (TAMR) is advisable because of the excellent long-term patency of arterial conduits. We present early and midterm outcomes of five different surgical configurations for TAMR. Between January 1998 and May 2004, 112 patients (aged 56.5 +/- 4.5 years, 20% female) with three-vessel disease underwent TAMR. The internal mammary arteries (IMAs) were harvested in a sketelonized fashion. The surgical techniques for TAMR consisted in Y or T composite grafts (n = 88, 78%) constructed between the in situ right IMA (RIMA) and the free left IMA (LIMA) graft (n = 58) or the radial artery (n = 30) (RA) in three different configurations. The other techniques consisted in T- and inverted T-graft (n = 24, 22%) constructed between the RA conduit and the free LIMA graft in two different configurations. The mean follow-up time was 40 +/- 23 months. Postoperative angiographic control was performed in 76/111 (70%) patients. Overall, 472 arterial anastomoses (average 4.2 per patient) were performed. One (0.9%) patient, undergoing the inverted T-graft technique, died on postoperative day 2. Another patient (0.9%), undergoing the lambda-graft technique using both IMAs and RA, suffered a new myocardial infarction probably due to RA conduit vasospasm. One week after surgery, after the transthoracic echocardiographic Doppler with adenosine provocative test, the coronary flow reserve (CFR) at the LIMA and RIMA main stems were 2 +/- 0.4 and 2.4 +/- 0.3, respectively. At 12-month follow-up, after adenosine provocative test, the CFRs at the LIMA and RIMA stems were significantly higher than the values at 1 week after surgery within the same group; (LIMA)CFR (1 week) 2.4 +/- 0.3 (12 months) vs 2 +/- 04 (1 week), P = 0.002; (RIMA)CFR 2.58 +/- 0.4 vs 2.4 +/- 0.3, P = 0.001. The CFR at the RIMA main stem was higher in all measurements within the same group than in the LIMA main stem, but not significantly. In one patient undergoing the lambda-graft technique using both IMAs, the RIMA was found to have a string sign. Postoperative angiography in 50 patients showed that the patency rate for the LIMA was 100%, for the RIMA 97.3%, and for the RA 96.7%. Angiography at 3-year follow-up in 76 patients documented excellent patency rates of the LIMA (97.4%), RIMA (95%), and RA (87%). Survival at 7 years was 92.5%, event-free survival 89.3%, and freedom from angina 94%. Total arterial myocardial revascularization using different surgical configurations is safe and effective. The use of composite arterial grafts provides excellent clinical and angiographic results, with a low rate of angina recurrence and late cardiac events. These configurations allow for complete arterial revascularization. FAU - Bonacchi, Massimo AU - Bonacchi M AD - Cattedra e Scuola di Specializzazione in Cardiochirurgia, University Hospital of Florence Careggi, Florence, Italy. mbonacchi@unifi.it FAU - Prifti, Edvin AU - Prifti E FAU - Maiani, Massimo AU - Maiani M FAU - Frati, Giacomo AU - Frati G FAU - Giunti, Gabriele AU - Giunti G FAU - Di Eusanio, Marco AU - Di Eusanio M FAU - Di Eusanio, Giuseppe AU - Di Eusanio G FAU - Leacche, Marzia AU - Leacche M LA - eng PT - Journal Article PL - Japan TA - Heart Vessels JT - Heart and vessels JID - 8511258 SB - IM MH - Adult MH - Aged MH - Blood Flow Velocity MH - Cardiopulmonary Bypass MH - Coronary Angiography MH - Coronary Disease/diagnosis/*surgery MH - Echocardiography, Doppler MH - Female MH - Graft Occlusion, Vascular MH - Humans MH - Internal Mammary-Coronary Artery Anastomosis MH - Male MH - Middle Aged MH - Myocardial Revascularization/*methods MH - Postoperative Complications MH - Radial Artery/transplantation MH - Statistics, Nonparametric MH - Survival Rate MH - Treatment Outcome MH - Vascular Patency EDAT- 2006/03/22 09:00 MHDA- 2007/05/16 09:00 CRDT- 2006/03/22 09:00 PHST- 2005/01/18 00:00 [received] PHST- 2005/07/23 00:00 [accepted] PHST- 2006/03/22 09:00 [pubmed] PHST- 2007/05/16 09:00 [medline] PHST- 2006/03/22 09:00 [entrez] AID - 10.1007/s00380-005-0856-2 [doi] PST - ppublish SO - Heart Vessels. 2006 Mar;21(2):69-77. doi: 10.1007/s00380-005-0856-2.